These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32271880)

  • 21. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active epithelial Hippo signaling in idiopathic pulmonary fibrosis.
    Gokey JJ; Sridharan A; Xu Y; Green J; Carraro G; Stripp BR; Perl AT; Whitsett JA
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
    Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization.
    Moon S; Kim W; Kim S; Kim Y; Song Y; Bilousov O; Kim J; Lee T; Cha B; Kim M; Kim H; Katanaev VL; Jho EH
    EMBO Rep; 2017 Jan; 18(1):61-71. PubMed ID: 27979972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
    Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
    Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.
    Hermann A; Wennmann DO; Gromnitza S; Edeling M; Van Marck V; Sudol M; Schaefer L; Duning K; Weide T; Pavenstädt H; Kremerskothen J
    Hepatology; 2018 Apr; 67(4):1546-1559. PubMed ID: 29116649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
    Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
    Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
    Liu J; Li J; Chen H; Wang R; Li P; Miao Y; Liu P
    J Cell Mol Med; 2020 May; 24(10):5786-5796. PubMed ID: 32281270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer.
    Tang Y; Fang G; Guo F; Zhang H; Chen X; An L; Chen M; Zhou L; Wang W; Ye T; Zhou L; Nie P; Yu H; Lin M; Zhao Y; Lin X; Yuan Z; Jiao S; Zhou Z
    Cancer Cell; 2020 Jul; 38(1):115-128.e9. PubMed ID: 32589942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer.
    Yan C; Yang H; Su P; Li X; Li Z; Wang D; Zang Y; Wang T; Liu Z; Bao Z; Dong S; Zhuang T; Zhu J; Ding Y
    Oncogene; 2022 Nov; 41(48):5186-5198. PubMed ID: 36271031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of TP73 transcription by Hippo-YAP signaling.
    Wen Z; Wang Y; Qi S; Ma M; Li J; Yu FX
    Biochem Biophys Res Commun; 2020 Oct; 531(2):96-104. PubMed ID: 32773110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting IRF3 as a YAP agonist therapy against gastric cancer.
    Jiao S; Guan J; Chen M; Wang W; Li C; Wang Y; Cheng Y; Zhou Z
    J Exp Med; 2018 Feb; 215(2):699-718. PubMed ID: 29339449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.
    Chen Q; Zhang N; Xie R; Wang W; Cai J; Choi KS; David KK; Huang B; Yabuta N; Nojima H; Anders RA; Pan D
    Genes Dev; 2015 Jun; 29(12):1285-97. PubMed ID: 26109051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidation of a universal size-control mechanism in Drosophila and mammals.
    Dong J; Feldmann G; Huang J; Wu S; Zhang N; Comerford SA; Gayyed MF; Anders RA; Maitra A; Pan D
    Cell; 2007 Sep; 130(6):1120-33. PubMed ID: 17889654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).
    Oka T; Mazack V; Sudol M
    J Biol Chem; 2008 Oct; 283(41):27534-27546. PubMed ID: 18640976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
    Chen M; Wang M; Xu S; Guo X; Jiang J
    Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.